January 5, 2017 / 1:50 PM / 8 months ago

BRIEF-Pfizer announces positive top-line results from study for potential Humira biosimilar

Jan 5 (Reuters) - Pfizer Inc :

* Pfizer announces positive top-line results from the comparative reflections B538-02 study for PF-06410293, a potential biosimilar to Humira1 (adalimumab)

* Pfizer Inc - comparative, confirmatory reflections B538-02 study met its primary objective Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below